InvestorsHub Logo
Followers 33
Posts 2835
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Wednesday, 10/05/2022 3:28:47 PM

Wednesday, October 05, 2022 3:28:47 PM

Post# of 265
SITC titles

Multiplexed TCR-T cell therapy targeting MAGEA1 and PRAME to enhance TCR-T therapeutic efficacy

Discovery of TSC-203-A02: A PRAME-specific TCR-T cell therapy candidate for the treatment of solid tumors
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TCRX News